Cellmark Forensics Inc  

(Public, NASDAQ:ORCH)   Watch this stock  
Find more results for ORCH
- Close
NASDAQ real-time data - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/235,106.00
Mkt cap 84.10M
P/E     -
Div/yield     -
EPS -0.22
Shares     -
Beta 1.46
Inst. own     -

Key stats and ratios

Q3 (Sep '11) 2010
Net profit margin -8.24% -7.10%
Operating margin -7.23% -5.14%
EBITD margin - 3.34%
Return on average assets -11.00% -8.58%
Return on average equity -14.35% -10.34%
Employees 530 -
CDP Score - -


4390 US Route One
United States - Map
+1-609-7502200 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Orchid Cellmark Inc. is engaged in the provision of deoxyribonucleic acid testing services that generate genetic profile information by analyzing an organism�s unique genetic identity. The Company also provides non-DNA forensic laboratory services. The Company�s business is primarily focused on DNA testing for human identity. It provides DNA testing services for forensic, family relationship and, to a lesser extent, security applications. It also provides DNA testing services for agricultural applications, primarily in selective trait breeding. It provides agricultural susceptibility testing. In December 2011, Laboratory Corporation of America Holdings completed the acquisition of Orchid Cellmark Inc., through its wholly owned subsidiary, OCM Acquisition Corp. (OCM). OCM acquired a 90% interest in Orchid Cellmark In., and OCM has effected as of December 15, 2011, a short-form merger with Orchid Cellmark Inc.